These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 7320021)

  • 21. [An immunogenicity and reactogenicity study of a purified, inactivated trivalent influenza vaccine for parenteral administration prepared for the 1996-1997 season].
    Lupulescu E; Ioniţă E; Botez D; Matepciuc M; Tabra ME; Tecu C; Alexandrescu V; Munţiu A
    Bacteriol Virusol Parazitol Epidemiol; 1997; 42(1-2):110-2. PubMed ID: 9235136
    [No Abstract]   [Full Text] [Related]  

  • 22. Immunogenicity and safety of inactivated influenza virus vaccine in young children in 2003-2004.
    Mitchell DK; Ruben FL; Gravenstein S
    Pediatr Infect Dis J; 2005 Oct; 24(10):925-7. PubMed ID: 16220095
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A one-year study of trivalent influenza vaccines in primed and unprimed volunteers: immunogenicity, clinical reactions and protection.
    Masurel N; Laufer J
    J Hyg (Lond); 1984 Jun; 92(3):263-76. PubMed ID: 6736638
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [A comparative study of live and inactivated influenza vaccines: the organization of the observation and the results of a study of their reactogenicity and immunogenicity].
    Slepushkin AN; Rudenko LG; Kendal AP; Monto AS; Beliaev AL; Burtseva EI; Grigor'eva EP; Obrosova-Serova NP; Ivanova VT; Bragina VE
    Vopr Virusol; 1994; 39(3):129-31. PubMed ID: 8091754
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Efficacy of inactivated and cold-adapted vaccines against influenza A infection, 1985 to 1990: the pediatric experience.
    Neuzil KM; Dupont WD; Wright PF; Edwards KM
    Pediatr Infect Dis J; 2001 Aug; 20(8):733-40. PubMed ID: 11734733
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical reactions and antibody responses to influenza vaccines. A comparison of split or subunit vaccines in children and young adults.
    Bernstein DI; Cherry JD
    Am J Dis Child; 1983 Jul; 137(7):622-6. PubMed ID: 6858973
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Safety and immunogenicity of MF59-adjuvanted influenza vaccine in the elderly.
    De Donato S; Granoff D; Minutello M; Lecchi G; Faccini M; Agnello M; Senatore F; Verweij P; Fritzell B; Podda A
    Vaccine; 1999 Aug; 17(23-24):3094-101. PubMed ID: 10462245
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Immunogenicity and safety of a quadrivalent inactivated influenza virus vaccine compared with a comparator quadrivalent inactivated influenza vaccine in a pediatric population: A phase 3, randomized noninferiority study.
    Airey J; Albano FR; Sawlwin DC; Jones AG; Formica N; Matassa V; Leong J
    Vaccine; 2017 May; 35(20):2745-2752. PubMed ID: 28390934
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Reactogenicity and serologic response to trivalent inactivated A/Texas, A/USSR and B/Hong Kong whole-virus influenza vaccine in human volunteers.
    Lavergne B; Frappier-Davignon L; Chagnon A; Burr-Paxton M; Quevillon M; Pavilanis V; Beaulnes A
    Can J Public Health; 1980; 71(1):25-31. PubMed ID: 6991090
    [No Abstract]   [Full Text] [Related]  

  • 30. [The inoculation properties of live recombinant influenza vaccine types A and B used separately and jointly in children 3 to 14].
    Rudenko LG; Ramirez A; Barro M; Gushchina MI; Armanda RE; Ermachenko TA; Romanova IuR; Grigor'eva EP; Aleksandrova GI; Lonskaia NI
    Vopr Virusol; 1991; 36(6):472-4. PubMed ID: 1785181
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Single-dose trials of monovalent A/New Jersey/76 (Hsw1N1) influenza virus vaccine in children in Durham, North Carolina.
    Gutman LT; Wilfert CM; Idriss ZH; Schmidt E; Andrews S; Katz SL
    J Infect Dis; 1977 Dec; 136 Suppl():S575-8. PubMed ID: 606774
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A Phase III randomised trial of the immunogenicity and safety of quadrivalent versus trivalent inactivated subunit influenza vaccine in adult and elderly subjects, assessing both anti-haemagglutinin and virus neutralisation antibody responses.
    van de Witte S; Nauta J; Montomoli E; Weckx J
    Vaccine; 2018 Sep; 36(40):6030-6038. PubMed ID: 29709447
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Vaccination activity of live influenza vaccine in different seasons of the year.
    Zykov MP; Sosunov AV
    J Hyg Epidemiol Microbiol Immunol; 1987; 31(4):453-9. PubMed ID: 3429857
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Safety and immunogenicity of split vaccines of influenza viruses].
    Zhu CL; Fang HH; Zhu FC; Wang YQ; Wu XL; Xue FB; Shen YJ; Lian JZ
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2004 Sep; 18(3):207-9. PubMed ID: 15640848
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The serological response of experimental animals to inactivated whole and split influenza virus vaccines.
    Fenton RJ; Jennings R; Potter CW
    J Biol Stand; 1977; 5(3):217-29. PubMed ID: 893466
    [No Abstract]   [Full Text] [Related]  

  • 36. Antibody response to inactivated influenza vaccines of various antigenic concentrations.
    Sullivan KM; Monto AS; Foster DA
    J Infect Dis; 1990 Feb; 161(2):333-5. PubMed ID: 2299213
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparison of the reactogenicity and immunogenicity of a split and a subunit-adjuvanted influenza vaccine in elderly subjects.
    Squarcione S; Sgricia S; Biasio LR; Perinetti E
    Vaccine; 2003 Mar; 21(11-12):1268-74. PubMed ID: 12559808
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Efficacy of inactivated vaccine in preventing antigenically drifted influenza type A and well-matched type B.
    Sugaya N; Nerome K; Ishida M; Matsumoto M; Mitamura K; Nirasawa M
    JAMA; 1994 Oct; 272(14):1122-6. PubMed ID: 7933325
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Reactions and serologic responses in young children and infants after administration of inactivated monovalent influenza A vaccine.
    Marine WM; Stuart-Harris C
    J Pediatr; 1976 Jan; 88(1):26-30. PubMed ID: 1245938
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Reactivity and antibody response to vaccination with bivalent influenza A/Victoria/75-A/New Jersey/76 vaccines in children with chronic pulmonary diseases.
    Hilman BC; Jamison RM; Kirkpatrick CJ
    J Infect Dis; 1977 Dec; 136 Suppl():S638-44. PubMed ID: 606786
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.